CANSINOBIO (06185.HK) announced that its self-developed 24-valent pneumococcal polysaccharide conjugate vaccine ...

Please provide your email address to receive an email when new articles are posted on . To avoid uncertainty, an expert recommends physicians understand each vaccine’s serotypes and which ones are ...

The Australian government announced last week there's a new vaccine for pneumococcal disease on the National Immunization Program for all children. Pneumococcus is also responsible for most ...

Human antibodies to bacterial polyaaccharides consist primarily of IgG and are largely restricted to the IgG2 subclass. We examined the ontogeny of the IgG subclass response to pneumococcal ...

"We [in medicine] tend to want to deliver a lot of data," says William Schaffner, MD, Professor of Preventive Medicine at Vanderbilt Medical Center. "Information is critical," he says, "but what's ...